Clinical Manufacturing Site Approved for Molecular Profiles

UK-based contract research and manufacturing organization Molecular Profiles has opened its new facility following a successful inspection from the Medicines and Healthcare products Regulatory Agency (MHRA). The Nottingham-based, pharmaceutical production site will provide clinical manufacturing capabilities.

This new facility marks a significant expansion for the company that started life as a spin-out from Nottingham University more than 15 years ago, the company reports. The investment adds six GMP suites, new laboratories, and a clinical packing area to support clients’ Phase I and II clinical trial projects.

The approval of the company’s cGMP-compliant facility follows a recent visit from Nick Clegg, Deputy Prime Minister of the UK Government, which provided £1.6m to the expansion through the regional growth fund grant. The new manufacturing site supports Molecular Profiles’ alliance with Onyx Scientific, which delivers pharmaceutical development services from drug discovery through the later phases of clinical development.